Prestige Consumer Healthcare IncPBH
Price$44.77Intrinsic value$63.4242% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $63.42median of 6 methods · middle span $54-$101based on filings through 30 Jun 2026
Market Price $44.77Price as of 1 Oct 2026
Margin of Safety +41.7%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 18.5% (near-term consensus, capped) · years 2–5: 1.7%/yr (balance of the path).4.9% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 62.3%Yr 73.0%Yr 83.6%Yr 94.2%Yr 104.8%
1.7% → 4.8%
Years 11–20: glide to long-run rate
Per-year rates
Yr 114.6%Yr 124.4%Yr 134.3%Yr 144.1%Yr 153.9%Yr 163.7%Yr 173.5%Yr 183.4%Yr 193.2%Yr 203.0%
4.8% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 2 windows (5/6y) (limited history)4.8%
Discount rate (cost of equity) 7.4%
Volatility vs market (adjusted beta)0.55

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetPrestige Consumer Healthcare IncPBHHealth Care
Valuation
P/E12.5×
P/S2.0×
P/B1.1×
EV / Revenue3.7×
EV / EBITDA9.9×
Profitability
Gross margin54.7%
Operating margin28.4%
Net margin15.6%
FCF margin21.3%
Returns
ROE9.0%
ROA3.8%
ROIC4.5%
Growth
Revenue growth (YoY)-2.9%
5-yr fwd EPS growth6.9%
Financial strength
Debt / Equity1.05×
Current ratio3.23×
Altman Z-Score1.6
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.